STOCK TITAN
  1. Home
  2. CLSN

CLSN (CLSN) Stock Price, News & Analysis

CLSN

Company Description

CLSN (Nasdaq: CLSN) carries a market capitalization of $13.9M.

This page collects what Stock Titan holds for CLSN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$13.9M
Market Cap
0.0
Shares outstanding

Latest News

View All
0.00%

Celsion Corporation Announces Company Name Change to Imunon, Inc.

+0.48%

Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer

clinical trial
-5.41%

Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13

+7.69%

Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment Conference

conferences
-1.90%

Celsion Corporation Highlights Progress in its DNA-based Vaccine Program

-1.55%

Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update

earnings

CLSN has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, conferences, earnings, management. View all CLSN news →

SEC Filings

View All

No SEC filings available for CLSN.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the market cap of CLSN (CLSN)?

The market cap of CLSN (CLSN) is approximately 13.9M. Learn more about what market capitalization means .